Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
63 hedge funds and large institutions have $110M invested in Apollo Endosurgery, Inc. in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 19 closing their positions.
105,300% more call options, than puts
Call options by funds: $6.32M | Put options by funds: $6K
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
11% less funds holding
Funds holding: 71 → 63 (-8)
37% less capital invested
Capital invested by funds: $173M → $110M (-$63.1M)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.21M |
| 2 |
Citigroup
New York
|
+$2.15M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.78M |
| 4 |
GS
Gagnon Securities
New York
|
+$1.26M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$753K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$1.88M |
| 2 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
-$1.29M |
| 3 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$1.12M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$758K |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
-$681K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ECM
76
ExodusPoint Capital Management
New York
| – | -$64K | -10,540 | Closed |
|
|
CSS
77
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$63K | -10,400 | Closed |
|
|
WCA
78
Waypoint Capital Advisors
Minneapolis,
Minnesota
| – | -$58K | -10,000 | Closed |
|
79
Simplex Trading
Chicago,
Illinois
| – | -$40K | -8,470 | Closed |
|
80
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4.63K | -980 | -91% |
|
APEN Hedge Fund Activity: Q2 2022 in Review
63 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2022, worth a combined $110M — down 37% from $173M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of APEN and 11 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 21 added.
The largest buyer was Stonepine Capital Management, adding an estimated $2.21M. The largest seller was Invesco, exiting entirely with an estimated $1.88M sold.
- 63 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2022, down from 71 in Q1 2022.
- Funds reported $110M of Apollo Endosurgery, Inc. stock for Q2 2022, down 37% quarter-over-quarter.
- 11 funds opened new Apollo Endosurgery, Inc. positions in Q2 2022 and 19 closed out, a net change of -8 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q2 2022 was Stonepine Capital Management, an estimated $2.21M added.
- The largest Apollo Endosurgery, Inc. seller in Q2 2022 was Invesco, an estimated $1.88M sold.
Based on aggregated 13F filings for Q2 2022.